SEGALA, D.; BARBIERI, M.; DI NUZZO, M.; BENAZZI, M.; BONAZZA, A.; ROMANINI, L.; QUARTA, B.; SCOLZ, K.; MARRA, A.; CAMPIONI, D.; CULTRERA, R. Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network. Global and Regional Health Technology Assessment, [S. l.], v. 11, n. Suppl. 2, p. 5–12, 2024. DOI: 10.33393/grhta.2024.3094. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3094. Acesso em: 12 sep. 2024.